Cardiac Imaging

What Is the Best Initial Imaging for High-Risk Chronic Chest Pain Without Known CAD?

·
What Is the Best Initial Imaging for High-Risk Chronic Chest Pain Without Known CAD?

A 62-year-old male with type 2 diabetes and hypertension presents to your clinic with a three-month history of substernal chest pressure. It reliably occurs when he walks up a flight of stairs and resolves with rest. His clinical picture points toward a high pre-test probability of coronary artery disease (CAD), but he has no prior cardiac diagnoses. You need to choose the right initial imaging study to confirm the diagnosis, assess its severity, and guide management. This article provides a focused workflow for this specific clinical scenario: initial imaging for chronic chest pain in a patient with a high probability of coronary artery disease but no known ischemic heart disease. Based on the American College of Radiology (ACR) Appropriateness Criteria, a transthoracic stress echocardiogram is rated Usually Appropriate and serves as an excellent starting point.

Who Fits This Clinical Scenario for Chronic Chest Pain?

This guidance applies specifically to patients presenting with chronic, stable chest pain where clinical suspicion for obstructive coronary artery disease is high. The key inclusion criteria are:

  • Symptom Pattern: The chest pain is chronic (present for weeks to months) and stable, typically exertional, and consistent with angina pectoris.
  • High Pre-Test Probability: The patient’s age, sex, symptom character, and risk factor profile (e.g., diabetes, hypertension, hyperlipidemia, smoking history, family history) place them in a high-likelihood category for having significant CAD.
  • No Known Ischemic Heart Disease: This is the patient’s initial diagnostic workup for these symptoms. They have not had a prior myocardial infarction, coronary stent, or bypass surgery.

This workflow should not be applied to patients with different presentations. For instance, a patient with acute, unremitting chest pain requires an emergency department evaluation for acute coronary syndrome (ACS). Similarly, a patient with a low pre-test probability of CAD may be better served by a different diagnostic strategy, potentially starting with a coronary artery calcium score or forgoing imaging altogether. Patients with known CAD who develop new or worsening symptoms fall under a separate ACR variant, as the clinical question shifts from initial diagnosis to assessing disease progression or graft/stent patency.

What Diagnoses Are You Working Up in This Scenario?

While the primary goal is to evaluate for flow-limiting coronary artery disease, the differential diagnosis for this presentation is focused on significant cardiac pathology.

The most common and critical diagnosis to confirm or exclude is obstructive coronary artery disease (CAD). In this high-probability scenario, the central question is not just if plaque is present, but whether it is causing hemodynamically significant stenosis that leads to myocardial ischemia during exertion. This is the classic mechanism for stable angina and the primary target of both medical and interventional therapies.

A functional stress test also helps evaluate for non-obstructive coronary ischemia. Some patients experience anginal symptoms due to microvascular dysfunction or endothelial dysfunction, where the major epicardial arteries are patent but smaller vessels fail to dilate properly with stress. A stress test showing evidence of ischemia without a corresponding obstructive lesion on subsequent angiography can point toward this diagnosis.

Less common but consequential causes of exertional chest pain include structural heart diseases that can be incidentally detected. Significant aortic stenosis, for example, can cause angina by increasing myocardial oxygen demand. Hypertrophic cardiomyopathy (HCM) can also present with chest pain. An echocardiogram, even at rest, provides valuable information on valvular function and myocardial thickness, making it a robust tool for assessing these possibilities simultaneously.

Why Is Stress Echocardiography the Recommended Initial Study for High-Risk Chronic Chest Pain?

For a patient with a high probability of CAD, the diagnostic question is primarily one of physiologic significance: is there evidence of inducible myocardial ischemia? A transthoracic stress echocardiogram directly answers this question, which is why the ACR rates it as Usually Appropriate.

The rationale for its leading position is multi-faceted. First, it is a functional test. By comparing cardiac wall motion at rest and at peak stress (either from exercise on a treadmill or pharmacologic agents like dobutamine), the study can identify regional wall motion abnormalities that signify downstream ischemia from a significant coronary stenosis. This provides more clinically actionable information than a purely anatomic test in this context. Second, it is highly accessible, cost-effective, and involves no ionizing radiation (0 mSv). It also provides crucial ancillary information, including baseline left ventricular ejection fraction, diastolic function, and an assessment of valvular heart disease.

Several other tests are also rated Usually Appropriate but are often reserved for specific situations or as second-line options:

  • Coronary CT Angiography (CTA): This is an excellent anatomic test that is particularly powerful for ruling out CAD in low-to-intermediate risk patients. In a high-risk patient, you fully expect to find plaque; the CTA may show moderate stenosis, but it cannot definitively determine if that lesion is causing ischemia. It also involves radiation (☢☢☢ 1-10 mSv) and iodinated contrast.
  • Invasive Coronary Angiography (Arteriography): This is the gold standard for defining coronary anatomy and the gateway to revascularization. However, it is an invasive procedure with associated risks (bleeding, stroke, vessel dissection). For initial diagnosis in stable chest pain, guidelines recommend a “non-invasive testing first” strategy. It is typically performed after a non-invasive test is positive and demonstrates a significant area of ischemia.
  • Nuclear Myocardial Perfusion Imaging (SPECT or PET): These are also excellent functional tests rated Usually Appropriate. They can be particularly useful in patients with poor acoustic windows on echocardiography or with baseline EKG changes (like a left bundle branch block) that can complicate interpretation. However, they involve higher radiation doses (☢☢☢☢ 10-30 mSv) compared to other modalities.

What’s Next After Stress Echocardiography? Downstream Workflow

The results of the stress echocardiogram will guide the subsequent clinical pathway. The decision tree is generally straightforward and aimed at optimizing medical therapy and identifying candidates for revascularization.

  • Positive for Ischemia: A finding of a new or worsening regional wall motion abnormality indicates inducible ischemia. The next step is a consultation with a cardiologist. Management will involve initiating or titrating guideline-directed medical therapy (e.g., antiplatelets, statins, beta-blockers, nitrates). Depending on the extent and severity of the ischemia and the patient’s symptoms, the cardiologist will likely recommend invasive coronary angiography to define the anatomy and consider percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
  • Negative for Ischemia: A normal stress echocardiogram with no evidence of inducible ischemia is highly reassuring and makes flow-limiting epicardial CAD an unlikely cause of the patient’s symptoms. The focus should shift to aggressive medical management of the patient’s cardiovascular risk factors (hypertension, diabetes, hyperlipidemia). If symptoms persist, other etiologies like microvascular disease or non-cardiac causes of chest pain should be explored.
  • Equivocal or Indeterminate: Sometimes, the study is technically limited (e.g., poor acoustic windows in a patient with obesity or COPD) or the findings are borderline. In this case, the clinician, often in consultation with a cardiologist, may proceed to a different non-invasive test, such as a nuclear stress test (SPECT/PET) or a coronary CTA, to gain more diagnostic clarity before considering an invasive approach.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for high-probability CAD requires careful patient selection and test interpretation. Common pitfalls include:

  • Misjudging Pre-Test Probability: Applying this high-risk algorithm to a low-risk patient can lead to over-testing and false-positive results. Use validated clinical risk scores to guide your initial assessment.
  • Choosing the Wrong Stressor: Ordering an exercise stress test for a patient who cannot walk or is on rate-limiting medications that prevent them from reaching their target heart rate will result in a non-diagnostic study. In these cases, a pharmacologic stress agent is necessary.
  • Ignoring Baseline EKG: A baseline EKG with a left bundle branch block, ventricular pacemaker, or significant ST-segment depressions makes the EKG portion of a stress test uninterpretable for ischemia. An imaging modality (echo or nuclear) is essential in these patients.
  • Dismissing Persistent Symptoms: If a patient has a negative stress test but continues to have classic, debilitating anginal symptoms, further evaluation may still be warranted, as no test is perfect.

If a patient’s symptoms change and become unstable—occurring at rest, with increasing frequency, or with minimal exertion—this represents a clinical escalation. The patient should be directed to the emergency department for an immediate workup for a possible acute coronary syndrome.

Related ACR Topics and Tools

For a comprehensive overview of all clinical variants related to this topic, further reading and specialized tools can provide additional context and support for ordering the correct imaging study.

Frequently Asked Questions

Why not start with a coronary CTA for a high-risk patient?

While a coronary CTA is rated ‘Usually Appropriate,’ its main strength is ruling out disease due to its high negative predictive value. In a patient with a high pre-test probability of CAD, you expect to find atherosclerotic plaque. The CTA will show you the anatomy (e.g., a 60% stenosis), but it won’t tell you if that lesion is causing ischemia. A functional test like a stress echo directly answers the physiologic question, which is more critical for guiding management in this population.

What if my patient cannot exercise on a treadmill?

If a patient cannot exercise due to orthopedic limitations, deconditioning, or other medical issues, a pharmacologic stress echocardiogram should be ordered. This uses an intravenous medication, typically dobutamine, to increase heart rate and contractility, simulating the effects of exercise to unmask potential ischemia.

Is a resting echocardiogram sufficient for this initial workup?

A resting transthoracic echocardiogram is rated ‘May be appropriate’ but is generally insufficient on its own. While it can identify a prior, unrecognized myocardial infarction (as a regional wall motion abnormality at rest) or significant structural issues like aortic stenosis, it cannot induce or detect ischemia. A normal resting echo does not rule out severe, flow-limiting CAD. The stress component is critical.

When should I proceed directly to invasive coronary angiography?

Proceeding directly to invasive angiography without a non-invasive stress test is generally reserved for patients with very high-risk features, such as those with unstable or accelerating anginal symptoms, evidence of heart failure, or life-threatening ventricular arrhythmias. For stable, chronic chest pain, even with high clinical suspicion, a non-invasive functional assessment is the standard first step.

Does a normal stress echo mean the patient has no coronary artery disease?

No. A normal stress echo indicates that there is no evidence of ischemia-inducing stenosis (typically >70%) in a major epicardial coronary artery. The patient may still have non-obstructive plaque or mild-to-moderate CAD that is not yet flow-limiting. The result is highly reassuring regarding the patient’s short-term risk of a major adverse cardiac event, and management should focus on aggressive risk factor modification to prevent disease progression.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026